icon-folder.gif   Conference Reports for NATAP  
 
  Digestive Disease Week
02nd - 05th June
2018 Washington, D.C
Back grey_arrow_rt.gif
 
 
 
PATTERNS OF DRUG AND ALCOHOL USE AND INJECTION RISK BEHAVIOURS AMONG PEOPLE WHO INJECT DRUGS DURING AND FOLLOWING HCV DIRECT-ACTING ANTIVIRAL TREATMENT: INSIGHTS FROM TRAJECTORY ANALYSES
 
 
  Reported by Jules Levin
Global Hepatitis Summit 2018 - June 14-17, 2018 - Toronto, Canada
 
Andreea A Artenie1,2, Evan B. Cunningham3, Brian Conway4, Olav Dalgard5, Jeff Powis6, Philip Bruggmann7, Margaret Hellard8,9, Curtis Cooper10, Phillip Read3,11 Jordan J Feld12, Behzad Hajarizadeh3, Janaki Amin3,13, Tanya L Applegate3, John F Dillon14, Chris Fraser15, Ed Gane16, Alain H. Litwin17, 18, Philippa Marks3, Gail V. Matthews3,19, Sophie Quiene3, Maria Christine Thurnheer20, Martin Weltman21, Gregory J Dore3,9, Julie Bruneau1,2 and Jason Grebely3 on behalf of the SIMPLIFY/D3FEAT Study Group

0619181

0619182

0619183

0619184

0619185

0619186